For science to move forwards, the research we do must be reproducible. One of the ways PromoCell is helping your work be as consistent as possible is through characterised Mesenchymal Stem Cells.
PromoCell announces services for large-scale industrial lots of Mesenchymal Stem Cells
New services for large-scale industrial lots allows customers to have high volumes of standardised MSC populations derived from bone marrow and adipose tissue. Read more at PromoCell.com
PromoCell announces services for the large-scale industrial lots of human mesenchymal stem cells (hMSCs). As a leading manufacturer of stem cell research products, PromoCell has over a decade of experience in the production of mesenchymal stem cells derived from bone marrow, umbilical cord and adipose tissue that ensure the highest level of standardization in accordance with ISCT* guidelines. With the growing demand for highly standardized MSC populations in cell-based therapy applications, PromoCell has now introduced their large-scale production service for mesenchymal stem cells derived from bone marrow and adipose tissue. The cells are offered as industrial lots that guarantee the access to a huge number of cells from the same lot with same specifications and quality.
Mesenchymal stem cells, also termed mesenchymal stromal cells, are multipotent cells that can differentiate into a variety of cell types and have the capacity for self-renewal. MSCs are capable of differentiating into different cell types e.g. adipocytes, chondrocytes, osteoblasts, myocytes, neurons, hepatocytes, and pancreatic islet cells and many more. Due to their relevant immunomodulatory properties, mesenchymal stem cells have received great attention in recent years with regard to their usage in cellular therapies.
“With significant sales and growing interest in mesenchymal stem cell applications throughout the world, we have taken an important step to offer services for large-scale industrial lots readily available to our customers’’ says Dr. Irma Boercsoek, COO of PromoCell.
Large-scale MSC production processes are a prerequisite for the commercial and clinical translation of cell-based therapies. A key requirement for this is the maintenance of a highly uniform cell population that retains all key characteristics of MSCs in a tightly defined manner. Meeting these requirements demands the highest degree of expertise in cell isolation, media manufacturing and quality control. By introducing large-scale industrial lots of MSCs that meet these criteria, PromoCell further enables the advancement of cell-based research applications.
Optimised PromoCell media are available to support both the growth of MSCs and their differentiation into several different lineages. ‘’Our brand stands for more than 29 years of expertise and a proven reputation in the production of world-class human cell culture products’’ adds Dr. Christian Gojak, Head of Marketing at PromoCell. Combined with its reliable profile and excellent scientific support, PromoCell offers researchers an efficacious solution to support consumer needs.